Triheptanoin

Triheptanoin (CAS No.: 620-67-7) is a synthetic odd chain medium chain triglyceride and glycerol triheptanoate analog that is broadly classified as a fatty acid metabolism modulator for biochemical and translational research, with a biological rationale rooted in its rapid hydrolysis to heptanoate and subsequent mitochondrial utilization as an anaplerotic carbon source that can replenish tricarboxylic acid cycle intermediates and influence cellular bioenergetic flux under conditions of metabolic stress; in current life sciences workflows it is primarily positioned within metabolic disease research, mitochondrial function studies, and mechanism focused drug discovery programs examining fatty acid oxidation biology and glucose transport related metabolic adaptation, while its mechanistic profile is generally interpreted through effects on beta oxidation linked energy production, ketone related substrate partitioning, and downstream modulation of energy sensing networks rather than high affinity interaction with a single canonical protein target, and because this compound is typically investigated as a nutrient like metabolic substrate rather than a receptor enzyme inhibitor, standardized in vitro potency metrics such as IC50, EC50, or MIC are often not reported in conventional nanomolar to micromolar target engagement terms, with activity instead characterized by concentration dependent shifts in respiration, metabolite labeling patterns, ATP homeostasis, and stress resilience across relevant cellular systems; accordingly, typical use cases include cell based metabolic challenge paradigms, isotope tracing experiments, mitochondrial stress assays, and in vivo studies of inherited metabolic dysfunction phenotypes, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, including model type, treatment duration, and selected biochemical endpoints in preclinical research settings.